{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:29:46Z","timestamp":1792146586329,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008839","name":"Shanghai Xuhui District Central Hospital","doi-asserted-by":"publisher","award":["23XHYD-20"],"award-info":[{"award-number":["23XHYD-20"]}],"id":[{"id":"10.13039\/501100008839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017633","name":"Shanghai Anti Cancer Association","doi-asserted-by":"publisher","award":["SACA-AX202211"],"award-info":[{"award-number":["SACA-AX202211"]}],"id":[{"id":"10.13039\/100017633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874182"],"award-info":[{"award-number":["81874182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["M \\u2212 0334"],"award-info":[{"award-number":["M \\u2212 0334"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217770","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:17:52Z","timestamp":1746213472000},"page":"217770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation"],"prefix":"10.1016","volume":"625","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-2582","authenticated-orcid":false,"given":"Jijun","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217770_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217770_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114046","article-title":"Unresectable biliary tract cancer: current and future systemic therapy","volume":"203","author":"Zhang","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/cam4.299","article-title":"Cisplatin\/gemcitabine or oxaliplatin\/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review","volume":"3","author":"Fiteni","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2025.217770_bib4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.21037\/hbsn-20-396","article-title":"Cholangiocarcinoma: a review of the literature and future directions in therapy","volume":"11","author":"Halder","year":"2022","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.canlet.2025.217770_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2025.217770_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216352","article-title":"Fatty acids in cancer chemoresistance","volume":"572","author":"Qin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217770_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-022-01340-1","article-title":"Posttranslational control of lipogenesis in the tumor microenvironment","volume":"15","author":"Zhu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217770_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40164-023-00420-3","article-title":"The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications","volume":"12","author":"Gu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217770_bib9","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41418-023-01228-8","article-title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A","volume":"30","author":"Mu","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217770_bib10","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217770_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13046-023-02854-3","article-title":"Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer","volume":"42","author":"Zheng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217770_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s13402-022-00722-4","article-title":"Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition","volume":"45","author":"Huang","year":"2022","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.canlet.2025.217770_bib13","article-title":"Recent advances in organoid development and applications in disease modeling","volume":"1875","author":"Rauth","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217770_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050481","article-title":"An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids","volume":"8","author":"Takahashi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2025.217770_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2017.07.084","article-title":"Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: preclinical models to improve HIPEC","volume":"531","author":"Roy","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.canlet.2025.217770_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","article-title":"Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance","volume":"5","author":"Zheng","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s11658-024-00665-8","article-title":"SENP3 mediates deSUMOylation of SIX1 to promote prostate cancer proliferation and migration","volume":"29","author":"Shao","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.canlet.2025.217770_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-023-01782-2","article-title":"The role of m6A methylation in therapy resistance in cancer","volume":"22","author":"Zhuang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib19","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1038\/s41388-023-02760-0","article-title":"Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy","volume":"42","author":"Gao","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217770_bib20","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.28508","article-title":"Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2025.217770_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-physiol-032122-030352","article-title":"Fatty acid transport and signaling: mechanisms and physiological implications","volume":"85","author":"Samovski","year":"2023","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.canlet.2025.217770_bib22","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/s41467-022-30153-6","article-title":"A negative-solvatochromic fluorescent probe for visualizing intracellular distributions of fatty acid metabolites","volume":"13","author":"Kajiwara","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217770_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100973","article-title":"Autophagy in liver diseases: a review","volume":"82","author":"Qian","year":"2021","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.canlet.2025.217770_bib24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217770_bib25","article-title":"IFI27 integrates succinate and fatty acid oxidation to promote adipocyte thermogenic adaption","volume":"10","author":"Cui","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.canlet.2025.217770_bib26","doi-asserted-by":"crossref","first-page":"14001","DOI":"10.1074\/jbc.272.22.14001","article-title":"Preferential modification of nuclear proteins by a novel ubiquitin-like molecule","volume":"272","author":"Kamitani","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2025.217770_bib27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nrm2293","article-title":"Concepts in sumoylation: a decade on","volume":"8","author":"Geiss-Friedlander","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2025.217770_bib28","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.canlet.2025.217770_bib29","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2025.217770_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.217770_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tibs.2007.05.002","article-title":"Modification in reverse: the SUMO proteases","volume":"32","author":"Mukhopadhyay","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2025.217770_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc.2016.143","article-title":"SUMO and the robustness of cancer","volume":"17","author":"Seeler","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","article-title":"Targeting SUMO signaling to wrestle cancer","volume":"7","author":"Kroonen","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101136","article-title":"CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation","volume":"77","author":"Gu","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2025.217770_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41523-024-00644-4","article-title":"Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer","volume":"10","author":"Powell","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib36","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41418-023-01175-4","article-title":"SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1","volume":"30","author":"Wu","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217770_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","article-title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.217770_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma","volume":"74","author":"Raggi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2025.217770_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41416-019-0711-3","article-title":"MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer","volume":"122","author":"Casciano","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217770_bib40","article-title":"Tumor cell-intrinsic CD96 mediates chemoresistance and cancer stemness by regulating mitochondrial fatty acid \u03b2-oxidation","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.canlet.2025.217770_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/bi00829a056","article-title":"Bile acids. XXVI. The metabolism of 12-alpha-hydroxycholanoic acid-24 14C in the rat","volume":"8","author":"Sonders","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.canlet.2025.217770_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1042\/BST0380034","article-title":"SUMO and ubiquitin paths converge","volume":"38","author":"Denuc","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.canlet.2025.217770_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/biom6010014","article-title":"Cooperativity of the SUMO and ubiquitin pathways in genome stability","volume":"6","author":"Nie","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.canlet.2025.217770_bib44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1097-2765(00)80133-1","article-title":"SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation","volume":"2","author":"Desterro","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.canlet.2025.217770_bib45","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.1802932115","article-title":"SUMO protease SENP1 deSUMOylates and stabilizes c-Myc","volume":"115","author":"Sun","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2025.217770_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41413-024-00363-3","article-title":"IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1\/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1\/2","volume":"12","author":"Deng","year":"2024","journal-title":"Bone Res."},{"key":"10.1016\/j.canlet.2025.217770_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122903","article-title":"m7G-modified mt-tRF3b-LeuTAA regulates mitophagy and metabolic reprogramming via SUMOylation of SIRT3 in chondrocytes","volume":"314","author":"Long","year":"2025","journal-title":"Biomaterials"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:36:01Z","timestamp":1762288561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S0304383525003362"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217770","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SENP3 induced HADHA deSUMOylation enhances intrahepatic cholangiocarcinoma chemotherapy sensitivity via fatty acid oxidation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217770"}}